Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Anette Woehl email, Mark Evans email, Anthony P Tetlow email and Philip McEwan email

Cardiovascular Diabetology 2008, 7:24doi:10.1186/1475-2840-7-24

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.